Comment from International Society for Pharmacoepidemiology

Summary: The International Society for Pharmacoepidemiology (ISPE) supports the FDA's draft guidance on the Plausible Mechanism Framework for individualized therapies. They provide specific recommendations to improve the guidance's rigor, clarity, and practical applicability, particularly regarding the use of real-world data, causal inference methods, and the characterization of natural history in rare diseases.